News

Cold chain solutions provider Sentry BioPharma Services is able to adapt to meet the diverse needs of its clients. With the proliferation of biopharma products that tend to be temperature-sensitive has come the need for more custom cold chain solutions. Fortunately, Sentry BioPharma Services exists to provide FDA compliant packaging solutions and supply chain management services to global […]

Sentry BioPharma Services’ chief executive talks about the company’s business highlights and industry trends. Tim Wright, Editor, Contract Pharma 10.14.20Sentry BioPharma Services is a wholesaler and third party logistics provider of prescription and investigational drug products, medical devices, and active pharmaceutical ingredients (APIs) for the pharmaceutical and medical device industry. Sentry’s founders created the contract […]

How Sentry maintained business continuity during the COVID-19 pandemic and beyond. Sentry Biopharma Services has a long history of experience in providing customized cold chain storage and distribution solutions across many temperature ranges as well as labeling, kitting, and packaging of clinical trial materials (CTM). Its clients require effective custom solutions for cold storage and distribution to […]

This Saturday, April 27th, 2019 several Sentry BioPharma Services team members will be proudly participating in the 2019 Komen Central Indiana Race for the Cure ®.  Over the years this event has raised more than $2 billion dollars to help fund research, education, screening and treatment.  This event is unique in that 100% of the […]

In its September issue, Pharmaceutical Commerce details the previous and expected contributions of biologic products to its forecast of cold-chain market growth predicting sales of cold-chain drugs and biologics will outpace overall industry growth through 2022. It is reported that “as of 2018, global sales of biotech drugs and biologic products exceed $300 billion in […]

In a recent news release the FDA described research it has conducted regarding detection of protein carbonylation, an oxidative reaction that may occur in therapeutic protein drug products during manufacture, storage, use, and transport potentially causing structural alterations and threatening stability, quality, and clinical efficacy of such products. FDA scientists have refined an antibody-binding assay […]

Sentry BioPharma Services is pleased to announce delegates from Sentry’s Business Development team will be in New York City attending the Drug, Chemical & Associated Technologies Association (DCAT) Week March 19th -22nd. The four-day conference brings together key sourcing, procurement and business development stakeholders within the industry’s top life science organizations.  The Sentry team’s focus […]

In a press release issued on August 1, 2017, The European Medicines Agency (EMA) announced that it “has developed and initiated a business continuity plan to deal with the uncertainty and workload implications linked to the United Kingdom’s (UK’s) withdrawal from the European Union (EU) and the Agency’s relocation”. It was indicated the plan is […]

Sentry BioPharma Services provides drug product management, global drug distribution, GMP storage and specialized services like pharmaceutical labeling, packaging and kitting.  Sentry plays a critical role in protecting temperature-sensitive product safety, identity, strength, purity and quality (SISPQ) for both clinical trials and commercial drug distribution for a wide range of pharmaceutical and biotechnology clients.   […]

JULY 6, 2017 INDIANAPOLIS, IN  Sentry BioPharma Services recently hosted a round table discussion with Congressman Trey Hollingsworth (IN 9th District) and representatives of BIO and the Indiana Health Industry Forum (IHIF).  BIO organized the event as a part of its “535 Congressional Initiative 2017”. BIO is the world’s largest trade association representing biotechnology companies, […]